INZY
Price
$4.00
Change
+$0.01 (+0.25%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
257.6M
43 days until earnings call
NTLA
Price
$9.37
Change
-$0.19 (-1.99%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
990.26M
31 days until earnings call
Interact to see
Advertisement

INZY vs NTLA

Header iconINZY vs NTLA Comparison
Open Charts INZY vs NTLABanner chart's image
Inozyme Pharma
Price$4.00
Change+$0.01 (+0.25%)
Volume$40.25K
Capitalization257.6M
Intellia Therapeutics
Price$9.37
Change-$0.19 (-1.99%)
Volume$79.42K
Capitalization990.26M
INZY vs NTLA Comparison Chart in %
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INZY vs. NTLA commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Buy and NTLA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (INZY: $3.99 vs. NTLA: $9.56)
Brand notoriety: INZY and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 187% vs. NTLA: 86%
Market capitalization -- INZY: $257.6M vs. NTLA: $990.26M
INZY [@Biotechnology] is valued at $257.6M. NTLA’s [@Biotechnology] market capitalization is $990.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • INZY’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, both INZY and NTLA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 3 TA indicator(s) are bullish while NTLA’s TA Score has 6 bullish TA indicator(s).

  • INZY’s TA Score: 3 bullish, 2 bearish.
  • NTLA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than INZY.

Price Growth

INZY (@Biotechnology) experienced а 0.00% price change this week, while NTLA (@Biotechnology) price change was +3.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.68%. For the same industry, the average monthly price growth was +32.84%, and the average quarterly price growth was +6.72%.

Reported Earning Dates

INZY is expected to report earnings on Aug 12, 2025.

NTLA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+3.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($990M) has a higher market cap than INZY($258M). INZY YTD gains are higher at: 44.043 vs. NTLA (-18.010). INZY has higher annual earnings (EBITDA): -100.34M vs. NTLA (-530.8M). NTLA has more cash in the bank: 504M vs. INZY (84.8M). INZY has less debt than NTLA: INZY (47M) vs NTLA (119M). NTLA has higher revenues than INZY: NTLA (45.6M) vs INZY (0).
INZYNTLAINZY / NTLA
Capitalization258M990M26%
EBITDA-100.34M-530.8M19%
Gain YTD44.043-18.010-245%
P/E RatioN/AN/A-
Revenue045.6M-
Total Cash84.8M504M17%
Total Debt47M119M39%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INZYNTLA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 18 days ago
87%
Bullish Trend 7 days ago
77%
Declines
ODDS (%)
N/A
Bearish Trend 18 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
86%
Aroon
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICEIX24.880.21
+0.85%
Macquarie International Core Eq I
FAPJX12.960.10
+0.78%
Fidelity Advisor Healthy Future A
VGIIX86.140.37
+0.43%
JPMorgan US Value I
SCAVX13.96-0.02
-0.14%
AB Small Cap Value A
IGNYX16.81-0.19
-1.12%
Macquarie Natural Resources Y

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with ACAD. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then ACAD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-0.25%
ACAD - INZY
49%
Loosely correlated
-0.41%
VCYT - INZY
43%
Loosely correlated
+2.13%
KROS - INZY
43%
Loosely correlated
-0.15%
PRME - INZY
41%
Loosely correlated
-8.68%
AURA - INZY
37%
Loosely correlated
-0.16%
More